medigraphic.com
Academia Mexicana de Neurología, A.C.

2018, Number 2

<< Back Next >>

Rev Mex Neuroci 2018; 19 (2)

Temporal lobe epilepsia caused by dysplasia type IIIa

Andrade-Machado R, Salazar-Peláez L

Language: Spanish
References: 26
Page: 86-98
PDF size: 540.03 Kb.


ABSTRACT

In this article we analyze whether there are clinical, radiological and histological findings of temporal lobe epilepsy caused by focal cortical dysplasia type IIIa and with these contribute to its clinical diagnosis. We performed a search in Pubmed and Medline with the following Mesh terms: dysplasia type IIIa, dysplasia type I, dysplasia type I and temporal lobe epilepsy, hippocampal sclerosis and dysplasia type I, reelin, filtered from 2010 to 2017. We considered letters to the editors, clinical observations, descriptive studies, cases and controls, prospective or retrospective studies, but in which the histological studies were published. We found that mesial temporal lobe epilepsy caused by focal cortical dysplasia type IIIa may be a specific disease with its own clinical, radiological findings and prognostic features. Perhaps it better individualization will depend on the contributions of molecular studies aiming to studying the impact of cell signaling pathway abnormalities, which would determine, both the death of hippocampal neurons and the dispersion of the dentate gyrus cells as well as the abnormal neuronal migration with the consequent cortical dislamination, abnormal neurons polarization and final position.


REFERENCES

  1. Siedlecka M., Grajkowska W., Galus R., Dembowska-Bagiska B., J??wiak J. Focal cortical dysplasia: Molecular disturbances and clinicopathological classification (Review). Int J Mol Med. 2016:1327-37, doi: 10.3892/ijmm.2016.2760.

  2. Blümcke I., Thom M., Aronica E., Armstrong DD., Vinters H V., Palmini A., et al. The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia. 2011;52(1):158-74, doi: 10.1111/j.1528-1167.2010.02777.x.

  3. Wu J., Li W., Chen Y., Kang L., Zhao W. Clinical characteristics of 92 patients with temporal lobe focal cortical dysplasia identified by pathological examination. J Clin Neurosci. 2015;21(12):2170-4, doi: 10.1016/j.jocn.2014.04.022.

  4. Tassi L., Garbelli R., Colombo N., Bramerio M., Lo Russo G., Deleo F., et al. Type i focal cortical dysplasia: Surgical outcome is related to histopathology. Epileptic Disord. 2010;12(3):181-91, doi: 10.1684/epd.2010.0327.

  5. Deleo F., Garbelli R., Milesi G., Gozzo F., Bramerio M., Villani F., et al. Short- and long-term surgical outcomes of temporal lobe epilepsy associated with hippocampal sclerosis: Relationships with neuropathology. Epilepsia. 2016;57(2):306-15, doi: 10.1111/epi.13277.

  6. Yao K., Duan Z., Zhou J., Li L., Zhai F., Dong Y., et al. Clinical and immunohistochemical characteristics of type II and type I focal cortical dysplasia. Oncotarget. 2016, doi: 10.18632/oncotarget.13001.

  7. Jin B., Wang J., Zhou J., Wang S., Guan Y., Chen S. A longitudinal study of surgical outcome of pharmacoresistant epilepsy caused by focal cortical dysplasia. J Neurol. 2016;263(12):2403-10, doi: 10.1007/s00415-016-8274-1.

  8. Kwon HE., Eom S., Kang H-C., Lee JS., Kim SH., Kim DS., et al. Surgical treatment of pediatric focal cortical dysplasia: Clinical spectrum and surgical outcome. Neurology. 2016;87(9):945-51, doi: 10.1212/WNL.0000000000003042.

  9. Xue H., Cai L., Dong S., Li Y. Clinical characteristics and post-surgical outcomes of focal cortical dysplasia subtypes. J Clin Neurosci. 2016;23:68-72, doi: 10.1016/j.jocn.2015.04.022.

  10. Fauser S., Essang C., Altenmüller DM., Staack A., Steinhoff BJ., Strobl K., et al. Is there evidence for clinical differences related to the new classification of temporal lobe cortical dysplasia? Epilepsia. 2013;54(5):909-17, doi: 10.1111/epi.12147.

  11. Fabera P., Krijtova H., Tomasek M., Krysl D., Zamecnik J., Mohapl M., et al. Familial temporal lobe epilepsy due to focal cortical dysplasia type IIIa. Seizure. 2015;31:120-3, doi: 10.1016/j.seizure.2015.07.014.

  12. Marucci G., Farnedi A., Giulioni M. Reelin: A possible link between hippocampal sclerosis and cortical dyslamination in the setting of FCD type IIIa. Neurol Sci. 2012;33(6):1479-81, doi: 10.1007/s10072-011-0895-7.

  13. Telese F., Ma Q., Perez PM., Notani D., Oh S., Li W., et al. LRP8-Reelin-Regulated Neuronal Enhancer Signature Underlying Learning and Memory Formation. Neuron. 2015;86(3):696-710, doi: 10.1016/j.neuron.2015.03.033.

  14. Stranahan AM., Salas-Vega S., Jiam NT., Gallagher M. Interference with reelin signaling in the lateral entorhinal cortex impairs spatial memory. Neurobiol Learn Mem. 2011;96(2):150-5, doi: 10.1016/j.nlm.2011.03.009.

  15. Rogers JT., Rusiana I., Trotter J., Zhao L., Donaldson E., Pak DTS., et al. Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density. Learn Mem. 2011;18(9):558-64, doi: 10.1101/lm.2153511.

  16. Scanlon C., Mueller SG., Cheong I., Hartig M., Weiner MW., Laxer KD. Grey and white matter abnormalities in temporal lobe epilepsy with and without mesial temporal sclerosis. J Neurol. 2013;260(9):2320-9, doi: 10.1007/s00415-013-6974- 3.

  17. Miyata H., Hori T., Vinters H V. Surgical pathology of epilepsy-associated non-neoplastic cerebral lesions: a brief introduction with special reference to hippocampal sclerosis and focal cortical dysplasia. Neuropathology. 2013;33(4):442- 58, doi: 10.1111/neup.12028.

  18. Blümcke I., Coras R., Miyata H., Özkara C. Defining clinico-neuropathological subtypes of mesial temporal lobe epilepsy with hippocampal sclerosis. Brain Pathology, vol. 22. 2012. p. 402-11.

  19. Blanc F., Martinian L., Liagkouras I., Catarino C., Sisodiya SM., Thom M. Investigation of widespread neocortical pathology associated with hippocampal sclerosis in epilepsy: A postmortem study. Epilepsia. 2011;52(1):10-21, doi: 10.1111/j.1528- 1167.2010.02773.x.

  20. Miyata H., Hori T., Vinters H V. Surgical pathology of epilepsy-associated non-neoplastic cerebral lesions: A brief introduction with special reference to hippocampal sclerosis and focal Cortical Dysplasia. Neuropathology. 2013;33(4):442- 58, doi: 10.1111/neup.12028.

  21. Simpson SL., Prayson R a. Post-surgical outcome for epilepsy associated with type I focal cortical dysplasia subtypes. Mod Pathol. 2014;27(11):1-6, doi: 10.1038/modpathol.2014.64.

  22. Johnson AM., Sugo E., Barreto D., Cunningham AM., Hiew CC., Lawson JA., et al. Response to ĞAbout Focal Cortical Dysplasia (FCD) type IIIağ. Epilepsy Res. 2014:1958-9, doi: 10.1016/j.eplepsyres.2014.09.027.

  23. Johnson AM., Sugo E., Barreto D., Cunningham AM., Hiew CC., Lawson JA., et al. Clinicopathological associations in temporal lobe epilepsy patients utilising the current ILAE focal cortical dysplasia classification. Epilepsy Res. 2014;108(8):1345-51, doi: 10.1016/j.eplepsyres.2014.06.013.

  24. Giulioni M., Marucci G., Martinoni M., Volpi L., Riguzzi P., Marliani AF., et al. Seizure outcome in surgically treated drugresistant mesial temporal lobe epilepsy based on the recent histopathological classifications. J Neurosurg. 2013;119(1):37- 47, doi: 10.3171/2013.3.JNS122132.

  25. Blümcke I., Thom M., Aronica E., Armstrong DD., Bartolomei F., Bernasconi A., et al. International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: A Task Force report from the ILAE Commission on Diagnostic Methods. Epilepsia. 2013;54(7):1315-29, doi: 10.1111/epi.12220.

  26. Rubboli G., Giulioni M., Volpi L., Martinoni M., Riguzzi P., Marucci G., et al. Seizure outcome and pathological correlation in drug-resistant temporal lobe epilepsy surgically treated. EpilepsiaConference 29th Int Epilepsy Congr IEC 2011 Rome ItalyConference Start 20110828 Conf End 20110901Conference Publ. 2011;52(Journal Article):191, doi: http://dx.doi. org/10.1111/j.1528-1167.2011.03207.x.




2020     |     www.medigraphic.com